Impact of Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for COVID-19 Adenovirus Vector Vaccines on European Healthcare Professionals.
van Vliet E, Lipovec NČ, van der Goot M, Abtahi S, Ribeiro-Vaz I, Poplavska E, Dermiki-Gkana F, Oikonomou C, Deligianni E, Kontogiorgis C, Silva AM, Ferreira PBS, Kos M, Almarsdóttir AB, Jacobsen R, Buhl C, de Bruijn A, Hegger I, Alves TL.
van Vliet E, et al. Among authors: kos m.
Pharmacoepidemiol Drug Saf. 2024 Dec;33(12):e70057. doi: 10.1002/pds.70057.
Pharmacoepidemiol Drug Saf. 2024.
PMID: 39586738
Free PMC article.